Accf/hrs/aha/ase/hfsa/scai/scct/scmr 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: A report of the …
AM Russo, RF Stainback, SR Bailey, AE Epstein… - Journal of the American …, 2013 - jacc.org
Journal of the American College of Cardiology, 2013•jacc.org
Abstract The American College of Cardiology Foundation in collaboration with the Heart
Rhythm Society and key specialty and subspecialty societies conducted a review of common
clinical scenarios where implantable cardioverter-defibrillators (ICDs) and cardiac
resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered
in this document address secondary prevention, primary prevention, comorbidities,
generator replacement at elective replacement indicator, dual-chamber ICD, and CRT.
Rhythm Society and key specialty and subspecialty societies conducted a review of common
clinical scenarios where implantable cardioverter-defibrillators (ICDs) and cardiac
resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered
in this document address secondary prevention, primary prevention, comorbidities,
generator replacement at elective replacement indicator, dual-chamber ICD, and CRT.
Abstract
The American College of Cardiology Foundation in collaboration with the Heart Rhythm Society and key specialty and subspecialty societies conducted a review of common clinical scenarios where implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered in this document address secondary prevention, primary prevention, comorbidities, generator replacement at elective replacement indicator, dual-chamber ICD, and CRT.
jacc.org